TP53 and cancer: The rationale for clustering CRC cell lines based on their MSI-High phenotype is that these cell lines are known to exhibit clinical, pathological, and molecular characteristics which distinguish them from MSS cancer cell lines and p53 is a key regulator of cellular processes.